Systemic Sclerosis Market: Exploring Current Therapeutics and Future Developments
Systemic sclerosis, commonly referred to as scleroderma, is a rare and complex autoimmune condition marked by vascular dysfunction, immune system dysregulation, and extensive fibrotic processes affecting both skin and internal organs. It is typically classified into two major forms: limited cutaneous systemic sclerosis and diffuse cutaneous systemic sclerosis—the latter being more severe...
0 Комментарии 0 Поделились 24 Просмотры 0 предпросмотр
Спонсоры